DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212052	MTX1	MTX1, AC234582.2			ENSG00000173171, ENSG00000236263			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155216951	GBAP1	GBAP1			ENSG00000160766			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q32.2	1	210816167	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3q26.2	3	169043635	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		38169	39864	rs75316749-G	rs75316749	0	75316749	intergenic_variant	1	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	HLA-B, HLA-B, HLA-B			ENSG00000228964, ENSG00000234745, ENSG00000206450			rs115392158-G	rs115392158	1	2507997	intron_variant	0	NR	9E-6	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6q14.1	6	80398959	Intergenic	RPL17P25 - AL359715.4	ENSG00000219547	ENSG00000279022		24390	41771	rs4604234-C	rs4604234	0	4604234	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	21951903	Intergenic	AL359922.1			ENSG00000264545			rs12349081-A	rs12349081	0	12349081	intron_variant	0	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3, ATXN2			ENSG00000111252, ENSG00000204842			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	4E-7	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-C	rs11907546	0	11907546	intergenic_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32265853	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467	intron_variant	0	NR	1E-7	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2325	1014	rs186507655-A	rs186507655	0	186507655	regulatory_region_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212373	MTX1	MTX1, AC234582.2			ENSG00000173171, ENSG00000236263			rs2075570-T	rs2075570	0	2075570	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3p24.1	3	27285723	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	4q24	4	105140377	Intergenic	AC004069.1			ENSG00000251259			rs7679673-A	rs7679673	0	7679673	intron_variant	0	NR	1E-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5q11.2	5	56737113	Intergenic	C5orf67 - AC008940.1	ENSG00000225940	ENSG00000228650		130881	33686	rs1862626-T	rs1862626	0	1862626	intergenic_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	29785031	Intergenic	AL645939.3 - HLA-V	ENSG00000270896	ENSG00000206507		21639	5923	rs147680653-G	rs147680653	1	9258375	regulatory_region_variant	1	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	HLA-B, HLA-B, HLA-B			ENSG00000228964, ENSG00000234745, ENSG00000206450			rs115392158-G	rs115392158	1	2507997	intron_variant	0	NR	3E-7	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	10q26.13	10	121575416	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q13.3	11	69227030	Intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55466	67108	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103813371	Intergenic	AP002989.1			ENSG00000254987			rs148883465-G	rs148883465	0	148883465	intron_variant	0	NR	3E-8	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.12	12	49251457	TUBA1C	AC010173.1, TUBA1C			ENSG00000258101, ENSG00000167553			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.13	12	52918828	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3, ATXN2			ENSG00000111252, ENSG00000204842			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000708, http://www.ebi.ac.uk/efo/EFO_0000571	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32394673	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818	intron_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	14q24.1	14	68559662	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-T	rs11907546	0	11907546	intergenic_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103745837	Intergenic	AP002989.1			ENSG00000254987			rs141752671-G	rs141752671	0	141752671	intron_variant	0	NR	1E-7	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111621753	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32295727	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113215368	PAX8	PAX8-AS1			ENSG00000189223			rs752590-?	rs752590	0	752590	intron_variant	0	0.21	3E-8	7.522878745280337		1.34	[1.21-1.49]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-12	11.096910013008056		1.3	[1.20-1.40]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-?	rs688187	0	688187	intergenic_variant	1	0.68	7E-13	12.154901959985743		1.4925373	[1.33-1.67]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q14.1	2	113258824	PAX8	PAX8-AS1, PAX8			ENSG00000189223, ENSG00000125618			rs72831838-?	rs72831838	0	72831838	intron_variant	0	0.14	8E-7	6.096910013008056	(Invasive Only)	1.39	[1.22-1.58]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	2q31.1	2	176172583	HOXD3	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-?	rs711830	0	711830	3_prime_UTR_variant	0	0.32	8E-7	6.096910013008056	(Invasive Only)	1.26	[1.15-1.39]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls	NA	19q13.2	19	39242112	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-?	rs688187	0	688187	intergenic_variant	1	0.68	1E-8	8.0	(Invasive Only)	1.4084507	[1.25-1.59]	Illumina [15504273] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST002967	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	18q21.1	18	48561565	CTIF	CTIF, CTIF			ENSG00000134030, ENSG00000282825			rs8091660-?	rs8091660	0	8091660	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003440	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4p15.33	4	13607505	BOD1L1	BOD1L1			ENSG00000038219			rs185229225-?	rs185229225	0	185229225	intron_variant	0	NR	2E-7	6.698970004336019				Illumina [6243550] (imputed)	N	ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003441	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	6q12	6	65027022	EYS	EYS			ENSG00000188107			rs201083182-?	rs201083182	0	201083182	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003439	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	5q23.2	5	122442912	MGC32805, SNCAIP	MGC32805, SNCAIP			ENSG00000250328, ENSG00000064692			rs3842595-?	rs3842595	0	3842595	intron_variant	0	NR	3E-7	6.522878745280337				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003439	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4q21.21	4	78088155	FRAS1	FRAS1			ENSG00000138759			rs150303591-?	rs150303591	0	150303591	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003440	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	3q24	3	143384827	SLC9A9	SLC9A9			ENSG00000181804			rs201023017-?	rs201023017	0	201023017	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003444	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	10q26.11	10	119607441	TIAL1	TIAL1 - RAD1P1	ENSG00000151923	ENSG00000234569		10412	13627	rs66696671-?	rs66696671	0	66696671	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003444	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	1q44	1	247193430	ZNF731P	AL390728.4			ENSG00000227671			rs12025262-?	rs12025262	0	12025262	intron_variant	0	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	13q21.2	13	61317943	PCDH20	MIR3169 - PCDH20	ENSG00000266663	ENSG00000280165		118063	91742	rs10674174-?	rs10674174	0	10674174	intergenic_variant	1	NR	8E-7	6.096910013008056				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	2p23.2	2	28097166	BRE	BABAM2			ENSG00000158019			rs7572644-?	rs7572644	0	7572644	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1p22.1	1	93933038	GCLM	MTCO1P21 - AL117351.1	ENSG00000226960	ENSG00000233129		4736	1441	rs185345278-A	rs185345278	0	185345278	intergenic_variant	1	0.0216	5E-6	5.301029995663981		2.8735633	[1.83-4.52]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1p12	1	119307920	HAO2	AL359915.1			ENSG00000227712			rs12031579-G	rs12031579	0	12031579	intron_variant	0	0.0547	8E-7	6.096910013008056		1.8248177	[1.44-2.31]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1q22	1	156114696	LMNA	LMNA			ENSG00000160789			rs188625872-C	rs188625872	0	188625872	5_prime_UTR_variant	0	0.0034	2E-6	5.698970004336019		3.7593985	[2.17-6.49]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	1q24.3	1	172072640	DNM3	DNM3			ENSG00000197959			rs12117623-C	rs12117623	0	12117623	intron_variant	0	0.5306	1E-6	6.0		1.312336	[1.18-1.46]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	2p11.2	2	86459965	KDM3A	KDM3A			ENSG00000115548			rs17027263-C	rs17027263	0	17027263	intron_variant	0	0.1172	2E-6	5.698970004336019		1.4430014	[1.24-1.68]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	3q27.3	3	186920430	RPL29P9	RPS20P14 - AC007690.1	ENSG00000223803	ENSG00000233565		19873	1856	rs6801612-A	rs6801612	0	6801612	regulatory_region_variant	1	0.683	8E-6	5.096910013008056		1.328	[1.174-1.503]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5p15.32	5	5169477	ADAMTS16	AC022424.2, ADAMTS16			ENSG00000250866, ENSG00000145536			rs12658731-G	rs12658731	0	12658731	intron_variant	0	0.6438	9E-7	6.045757490560675		1.405	[1.227-1.608]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5q31.2	5	139712729	CXXC5	AC008667.1			ENSG00000249526			rs147867139-A	rs147867139	0	147867139	intron_variant	0	0.0175	8E-6	5.096910013008056		2.197802	[1.56-3.11]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	5q35.3	5	180485036	CNOT6	RNU6-525P - CNOT6	ENSG00000200555	ENSG00000113300		40424	9376	rs60982503-G	rs60982503	0	60982503	regulatory_region_variant	1	0.7345	5E-6	5.301029995663981		1.384	[1.204-1.591]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6p24.3	6	10403963	TFAP2A	TFAP2A			ENSG00000137203			rs303051-A	rs303051	0	303051	intron_variant	0	0.3947	6E-6	5.221848749616356		1.2886598	[1.15-1.44]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6p21.31	6	35464877	FANCE	FANCE			ENSG00000112039			rs56855829-C	rs56855829	0	56855829	intron_variant	0	0.0036	2E-6	5.698970004336019		3.8022811	[2.18-6.62]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6q16.1	6	96284381	FUT9	RN7SL797P - UFL1-AS1	ENSG00000242560	ENSG00000233797		1518	73993	rs4599655-A	rs4599655	0	4599655	intergenic_variant	1	0.1365	8E-6	5.096910013008056		1.3927578	[1.21-1.61]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	6q24.3	6	146688554	C6orf103	ADGB			ENSG00000118492			rs73589840-C	rs73589840	0	73589840	intron_variant	0	0.0329	7E-6	5.154901959985743		1.7452006	[1.37-2.22]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	7p12.3	7	47770503	MGC16075	PKD1L1			ENSG00000158683			rs181474944-C	rs181474944	0	181474944	intron_variant	0	0.0150	6E-6	5.221848749616356		2.4570024	[1.67-3.62]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	7q21.13	7	89698682	ZNF804B	AC002383.1 - RNU6-274P	ENSG00000227863	ENSG00000239075		204420	55938	rs76926936-T	rs76926936	0	76926936	intergenic_variant	1	0.0517	9E-6	5.045757490560675		1.923077	[1.44-2.56]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	9q21.33	9	87680655	DAPK1	DAPK1			ENSG00000196730			rs10117922-A	rs10117922	0	10117922	intron_variant	0	0.325	7E-6	5.154901959985743		1.3351135	[1.18-1.51]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	9q34.3	9	135247660	C9orf62	AL390778.2			ENSG00000233936			rs10858374-T	rs10858374	0	10858374	intron_variant	0	0.1106	1E-6	6.0		1.4684289	[1.26-1.72]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	10q25.3	10	115937294	ATRNL1	ATRNL1			ENSG00000107518			rs2615880-A	rs2615880	0	2615880	intron_variant	0	0.1234	8E-6	5.096910013008056		1.4025246	[1.21-1.63]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70028700	C12orf28	LINC01481, LINC01481			ENSG00000257815, ENSG00000257613			rs789336-C	rs789336	0	789336	intron_variant	0	0.6082	1E-7	7.0		1.369	[1.217-1.540]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70148026	LOC100125409	LINC01481, LINC01481			ENSG00000257815, ENSG00000257613			rs7969255-T	rs7969255	0	7969255	intron_variant	0	0.5313	8E-7	6.096910013008056		1.325	[1.184-1.481]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70257391	CNOT2	CNOT2			ENSG00000111596			rs58355101-T	rs58355101	0	58355101	intron_variant	0	0.5658	9E-7	6.045757490560675		1.35	[1.198-1.521]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	12q15	12	70359064	CNOT2	CNOT2 - KCNMB4	ENSG00000111596	ENSG00000135643		4071	7212	rs1495352-A	rs1495352	0	1495352	intergenic_variant	1	0.5489	3E-6	5.522878745280337		1.31	[1.169-1.468]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	16q12.2	16	54596587	IRX3	LINC02183 - AC007491.1	ENSG00000283304	ENSG00000283258		37487	32376	rs75921351-C	rs75921351	0	75921351	intergenic_variant	1	0.0304	8E-7	6.096910013008056		2.1691973	[1.59-2.95]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	16q12.2	16	55347327	RPL31P56	AC109462.1 - RPL31P56	ENSG00000259283	ENSG00000240760		13739	5394	rs145065165-G	rs145065165	0	145065165	intergenic_variant	1	0.0223	2E-7	6.698970004336019		2.8735633	[1.93-4.29]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	17p13.2	17	5857509	LOC339166	AC007846.2, AC007846.1			ENSG00000285471, ENSG00000284837			rs11870446-C	rs11870446	0	11870446	intron_variant	0	0.1238	3E-6	5.522878745280337		1.4836795	[1.26-1.75]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	19q13.43	19	58202868	ZNF274	ZNF274			ENSG00000171606			rs12151036-G	rs12151036	0	12151036	intron_variant	0	0.0119	5E-6	5.301029995663981		2.2075055	[1.57-3.11]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	20q13.31	20	56648010	TFAP2C	TFAP2C - RNU6-1146P	ENSG00000087510	ENSG00000252091		8727	19420	rs1884920-A	rs1884920	0	1884920	intergenic_variant	1	0.5027	8E-6	5.096910013008056		1.4064697	[1.21-1.64]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls	NA	22q13.1	22	39341089	SYNGR1	RPL3 - SYNGR1	ENSG00000100316	ENSG00000100321		20700	8836	rs137672-C	rs137672	0	137672	regulatory_region_variant	1	0.0601	1E-7	7.0		1.7452006	[1.42-2.15]	Illumina [7521072] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST007239	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141643383	intergenic	RASA2 - AC092978.1	ENSG00000155903	ENSG00000242104		28041	17153	rs295315-?	rs295315	0	295315	intergenic_variant	1	NR	8E-7	6.096910013008056		1.82		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10q23.1	10	80608465	SH2D4B	SH2D4B			ENSG00000178217			rs17693104-?	rs17693104	0	17693104	intron_variant	0	NR	8E-7	6.096910013008056		1.65		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141658488	LOC646730	RASA2 - AC092978.1	ENSG00000155903	ENSG00000242104		43146	2048	rs868767-?	rs868767	0	868767	intergenic_variant	1	NR	2E-6	5.698970004336019		2.12		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	20p11.21	20	24451198	intergenic	GAPDHP53 - SYNDIG1	ENSG00000234069	ENSG00000101463		4884	18001	rs2050203-?	rs2050203	0	2050203	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.78		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	14q32.31	14	101629499	intergenic	AL049836.1			ENSG00000258919			rs11621975-?	rs11621975	0	11621975	intron_variant	0	NR	5E-6	5.301029995663981		2.31		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	12q23.2	12	102981636	intergenic	ASCL1 - AC068643.1	ENSG00000139352	ENSG00000257703		21120	99314	rs17548007-?	rs17548007	0	17548007	intergenic_variant	1	NR	5E-6	5.301029995663981		1.86		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	8q21.13	8	81290982	intergenic	FABP5 - AC018616.1	ENSG00000164687	ENSG00000253859		6205	148454	rs202280-?	rs202280	0	202280	regulatory_region_variant	1	NR	6E-6	5.221848749616356		2.0		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10p12.1	10	26722183	PDSS1	PDSS1			ENSG00000148459			rs1564271-?	rs1564271	0	1564271	intron_variant	0	NR	9E-6	5.045757490560675		1.62		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - AP003032.2	ENSG00000149262	ENSG00000254829		13888	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	9E-6	5.045757490560675		2.29		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	6p25.3	6	1492427	intergenic	FOXF2 - RN7SL352P	ENSG00000137273	ENSG00000243439		96824	14895	rs4618572-?	rs4618572	0	4618572	intergenic_variant	1	NR	9E-6	5.045757490560675		1.86		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - AP003032.2	ENSG00000149262	ENSG00000254829		13888	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	2E-7	6.698970004336019		2.74		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13492506	PTH	PTH			ENSG00000152266			rs6256-?	rs6256	0	6256	stop_gained	0	NR	1E-6	6.0		1.93		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13553087	intergenic	PTH - HMGN2P36	ENSG00000152266	ENSG00000228901		56906	57276	rs10832063-?	rs10832063	0	10832063	intergenic_variant	1	NR	5E-6	5.301029995663981		1.8		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13401400	BTBD10	BTBD10			ENSG00000148925			rs10500780-?	rs10500780	0	10500780	intron_variant	0	NR	5E-6	5.301029995663981		1.79		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2014-02-10	21964575	Rafnar T	2011-10-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21964575	Mutations in BRIP1 confer high risk of ovarian cancer.	Ovarian cancer	640 European ancestry cases, 41,607 European ancestry controls	NA	17q23.2	17	61803285	BRIP1	BRIP1			ENSG00000136492			rs34289250-C	rs34289250	0	34289250	intron_variant	0	0.0089	6E-13	12.221848749616356		7.95	[NR]	Illumina [15957390] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001258	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-A	rs7405776	0	7405776	intron_variant	0	0.58811	2E-7	6.698970004336019		1.25	[1.15-1.35]	Illumina [11595112] (imputed)	N	ovarian clear cell adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_1000042	GCST004417	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755	intron_variant	0	0.513535	7E-9	8.154901959985743		1.27	[1.16-1.37]	Illumina [11595112] (imputed)	N	ovarian clear cell adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_1000042	GCST004417	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q14.1	2	113215368	NR	PAX8-AS1			ENSG00000189223			rs752590-G	rs752590	0	752590	intron_variant	0	0.210808	2E-12	11.698970004336019		1.2968692	[1.20743024891207-1.39293308913389]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	1E-14	14.0		1.2736082	[1.19835894617868-1.35358269315725]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	1E-13	13.0		1.2623247	[1.18761263149067-1.34173680787849]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	3q23	3	139130269	NR	MRPS22			ENSG00000175110			rs112071820-GCCAG	rs112071820	0	112071820	intron_variant	0	0.283067	2E-13	12.698970004336019		1.2854952	[1.20336051010928-1.37323590882365]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	9q31.1	9	102180944	NR	ARL2BPP7 - RNU6-329P	ENSG00000230418	ENSG00000238882		125203	75660	rs320203-A	rs320203	0	320203	intergenic_variant	1	0.850197	2E-8	7.698970004336019		1.2856314	[1.17544642545976-1.4061450991104]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755	intron_variant	0	0.513535	2E-6	5.698970004336019		1.1539987		Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls	NA	19q13.2	19	39242112	NR	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819	1441	rs688187-A	rs688187	0	688187	intergenic_variant	1	0.312892	1E-22	22.0		1.4258754	[1.32592116400102-1.5333648423891]	Illumina [11595112] (imputed)	N	ovarian mucinous adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0006462	GCST004419	Genome-wide genotyping array
2009-09-04	19648919	Song H	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648919	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.	Ovarian cancer	1,817 European ancestry cases, 2,353 European ancestry controls	6,944 European ancestry cases, 9,477 European ancestry controls	9p22.2	9	16915023	BNC2, LOC648570, CNTLN	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		44180	2488	rs3814113-T	rs3814113	0	3814113	intergenic_variant	1	0.68	5E-19	18.30102999566398		1.22	[1.16-1.27]	Illumina [up to 2000000] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000455	Genome-wide genotyping array
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17278895	C19orf62, MERIT40	AC010463.1, USHBP1, BABAM1			ENSG00000269307, ENSG00000130307, ENSG00000105393			rs8170-T	rs8170	0	8170	synonymous_variant	0	NR	4E-6	5.3979400086720375	(Susceptibility)	1.12	[1.07-1.17]	Illumina [540573]	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000800	Genome-wide genotyping array
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17283315	ANKLE1	ANKLE1			ENSG00000160117			rs2363956-T	rs2363956	0	2363956	missense_variant	0	NR	1E-7	7.0	(Susceptibility)	1.1	[1.06-1.15]	Illumina [540573]	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000800	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	2q31.1	2	176177905	HOXD1, HOXD3	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs2072590-T	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	NR	5E-14	13.301029995663981		1.16	[1.12-1.21]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	3q25.31	3	156679960	TIPARP	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390	intron_variant	0	NR	3E-7	6.522878745280337		1.19	[1.11-1.27]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	8q24.21	8	128531703	MYC, THEM75	LINC00824			ENSG00000254275			rs10088218-G	rs10088218	0	10088218	intron_variant	0	NR	3E-9	8.522878745280337		1.19	[1.12-1.25]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48334138	SKAP1	SKAP1			ENSG00000141293			rs9303542-G	rs9303542	0	9303542	intron_variant	0	NR	1E-6	6.0		1.11	[1.06-1.16]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	1p36.12	1	22164231	NR	AL445253.1 - MIR4418	ENSG00000285873	ENSG00000266564		6830	102008	rs7521902-?	rs7521902	0	7521902	intergenic_variant	1	NR	5E-6	5.301029995663981		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	11p14.3	11	25186158	NR	AC087373.1 - RPL36AP40	ENSG00000255368	ENSG00000240298		45135	402317	rs12794435-?	rs12794435	0	12794435	intergenic_variant	1	NR	5E-6	5.301029995663981		1.16	[1.09-1.23]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48279758	NR	SKAP1			ENSG00000141293			rs2084881-?	rs2084881	0	2084881	intron_variant	0	NR	2E-6	5.698970004336019		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST000802	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		44180	2488	rs3814113-?	rs3814113	0	3814113	intergenic_variant	1	0.68	4E-29	28.397940008672037	(All invasive)	1.21	[1.17-1.25]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		44180	2488	rs3814113-?	rs3814113	0	3814113	intergenic_variant	1	0.68	4E-32	31.397940008672037	(Serious invasive)	1.28	[1.23-1.33]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	MYC	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	3E-12	11.522878745280337	(All invasive)	1.18	[1.13-1.24]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703	NR	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218	intron_variant	0	0.87	1E-17	17.0	(Serious invasive)	1.29	[1.21-1.36]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	5E-11	10.301029995663981	(All invasive)	1.11	[1.08-1.15]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs2072590-?	rs2072590	0	2072590	non_coding_transcript_exon_variant	0	0.32	3E-10	9.522878745280337	(Serious invasive)	1.13	[1.09-1.18]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-29	28.69897000433602	(All invasive)	1.44	[1.35-1.54]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446	intron_variant	0	0.05	2E-34	33.69897000433602	(Serious invasive)	1.59	[1.48-1.71]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	AC010463.1, USHBP1, BABAM1			ENSG00000269307, ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	2E-7	6.698970004336019	(All invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895	NR	AC010463.1, USHBP1, BABAM1			ENSG00000269307, ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170	synonymous_variant	0	0.19	3E-14	13.522878745280337	(Serious invasive)	1.19	[1.14-1.25]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	6E-9	8.221848749616356	(All invasive)	1.12	[1.08-1.16]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542	intron_variant	0	0.27	3E-10	9.522878745280337	(Serious invasive)	1.14	[1.09-1.18]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	6E-9	8.221848749616356	(All invasive)	1.19	[1.12-1.26]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652	intron_variant	0	0.07	7E-10	9.154901959985743	(Serious invasive)	1.24	[1.16-1.33]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	2E-8	7.698970004336019	(All invasive)	1.1	[1.06-1.13]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180	intron_variant	0	0.31	1E-7	7.0	(Serious invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q12	17	37736525	HNF1B, ACACA, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, TBC1D3F, TBC1D3, MRPL45, GPR179, SOCS7, ARHGAP23	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs757210-G	rs757210	0	757210	intron_variant	0	0.37	8E-10	9.096910013008056	(Serious invasive)	1.12	[1.08-1.17]	Illumina [2508744] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001941	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	intergenic	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-G	rs17631303	0	17631303	intron_variant	0	0.19	1E-8	8.0		1.27	[1.17-1.38]	Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	intergenic	NSF, NSF, NSF			ENSG00000278174, ENSG00000276262, ENSG00000073969			rs183211-A	rs183211	0	183211	intron_variant	0	0.23	3E-8	7.522878745280337		1.25	[1.16-1.35]	Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	4q32.3	4	164987569	intergenic	AC106872.4			ENSG00000248229			rs4691139-G	rs4691139	0	4691139	non_coding_transcript_exon_variant	0	0.48	3E-8	7.522878745280337		1.2	[1.17-1.38]	Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	9p22.2	9	16915023	intergenic	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		44180	2488	rs3814113-A	rs3814113	0	3814113	intergenic_variant	1	0.66	6E-11	10.221848749616356		1.3	[1.2-1.41]	Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	3q25.31	3	156679960	intergenic	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390	intron_variant	0	0.043	7E-6	5.154901959985743		1.46	[1.25-1.71]	Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-?	rs17631303	0	17631303	intron_variant	0	NR	1E-8	8.0				Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944	NR	NSF, NSF, NSF			ENSG00000278174, ENSG00000276262, ENSG00000073969			rs183211-?	rs183211	0	183211	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [2568349] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST001917	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous ovarian cancer	1,012 European ancestry cases, 40,941 European ancestry controls	NA	8q21.13	8	76408119	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538	intron_variant	0	0.978	1E-6	6.0		3.0	[1.79409543681435-5.01001565578963]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004461	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.220826	2E-7	6.698970004336019		1.099984	[1.06129080940929-1.14008804057615]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	3E-14	13.522878745280337		1.1312215	[1.09591680302958-1.16766347713436]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	2E-14	13.698970004336019		1.1323612	[1.09696977445389-1.1688944318043]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	3E-46	45.52287874528034		1.5885553	[1.49139660538722-1.69204355063709]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	2E-12	11.698970004336019		1.1303236	[1.09267833241685-1.16926591871766]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	6E-10	9.221848749616356		1.1067635	[1.07188995128973-1.14277166876843]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2E-9	8.698970004336019		1.1915798	[1.12527496598389-1.26179155485818]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	2E-24	23.69897000433602		1.2746594	[1.21607733088533-1.33606352682139]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	3E-43	42.52287874528034		1.3252935	[1.27262437839255-1.38014255146877]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	7E-11	10.154901959985743		1.1340009	[1.0921011879635-1.17750814490349]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	0	144962376	intron_variant	0	0.309302	7E-9	8.154901959985743		1.0992962	[1.06472642475689-1.13498849236897]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2631	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.133618999999999	1E-7	7.0		1.1235955	[1.08-1.18]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	2E-10	9.698970004336019		1.1048253	[1.07145224223974-1.13923779281726]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	1E-8	8.0		1.0903314	[1.05822261240111-1.12341446823123]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	3E-12	11.522878745280337		1.1472089	[1.10406141518038-1.19204274035159]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	1E-14	14.0		1.13894	[1.10200256244972-1.17711551141243]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	4E-24	23.397940008672037		1.1823713	[1.14473972413471-1.22123996090847]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	5E-9	8.301029995663981		1.1651025	[1.10668774857942-1.22660041924]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	4E-7	6.3979400086720375		1.0926361	[1.05582163841262-1.13073417257807]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	127805637	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651	intron_variant	0	0.461222	8E-6	5.096910013008056		1.0710524	[1.03930535696901-1.10376916464823]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	3E-7	6.522878745280337		1.0817573	[1.04973458497305-1.11475700006623]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004478	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	5E-8	7.301029995663981		1.1790794	[1.11145306187694-1.25082055006039]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	3E-6	5.522878745280337		1.1861752	[1.1045500086088-1.27383238173854]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	4q32.3	4	166265894	NR	TLL1 - RF00019	ENSG00000038295	ENSG00000200572		161999	47041	rs13113999-T	rs13113999	0	13113999	intergenic_variant	1	0.515695999999999	5E-8	7.301029995663981		1.2250321	[1.13870977824743-1.31789814351814]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	4E-9	8.397940008672037		1.2546542	[1.16419555293272-1.35214154339342]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	6E-19	18.221848749616356		1.3829999	[1.28830538018993-1.48465482476452]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	2E-12	11.698970004336019		1.4812524	[1.32210226140915-1.65956066549562]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	10q24.33	10	103934543	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16338	32658	rs7902587-T	rs7902587	0	7902587	intergenic_variant	1	0.0975691	9E-7	6.045757490560675		1.3209459	[1.18528926703463-1.47212825755187]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	5E-6	5.301029995663981		1.1726217	[1.09521694178849-1.25549703248424]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-6	5.096910013008056		1.1832383	[1.09949355363646-1.27336159916358]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275360999999999	9E-6	5.045757490560675		1.1853783	[1.10016620517041-1.27719049018494]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004479	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.220826	8E-8	7.096910013008056		1.1063784	[1.06640418255445-1.14785110269475]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	8E-13	12.096910013008056		1.1268522	[1.09069613461779-1.16420663147032]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	5E-13	12.301029995663981		1.1282876	[1.09203474654839-1.16574376009934]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	4E-49	48.39794000867204		1.630706	[1.52886835426178-1.73932685946596]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	5E-12	11.301029995663981		1.1310111	[1.09226786405932-1.17112854934655]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	2E-8	7.698970004336019		1.099452	[1.06380317084564-1.13629550714478]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	9E-10	9.045757490560675		1.2026194	[1.13408089642882-1.27530001906482]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-22	21.154901959985743		1.2638669	[1.20425676967645-1.32642773080558]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	1E-47	47.0		1.358497	[1.30256836396842-1.41682722055063]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	9q31.1	9	104094512	NR	SMC2			ENSG00000136824			rs4742903-T	rs4742903	0	4742903	intron_variant	0	0.563	6E-6	5.221848749616356		1.0740868	[1.04130585570624-1.10789968145028]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	5E-12	11.301029995663981		1.146201	[1.10275565491329-1.19135797504449]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	0	144962376	intron_variant	0	0.309302	2E-8	7.698970004336019		1.09834	[1.06283348839533-1.13503280772478]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2631	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.133618999999999	7E-8	7.154901959985743		1.1363636	[1.09-1.19]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	3E-9	8.522878745280337		1.1008928	[1.06665802122163-1.1362263861189]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	2E-8	7.698970004336019		1.0924964	[1.05939221330271-1.12663514204283]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-14	13.096910013008056		1.1383171	[1.1003320875334-1.17761354130912]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	3E-26	25.522878745280337		1.1971419	[1.15799210345029-1.23761537074498]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	4E-7	6.3979400086720375		1.0954511	[1.05748739051043-1.1347778353567]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	8E-7	6.096910013008056		1.0811644	[1.04824881016487-1.11511353852335]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	3E-13	12.522878745280337		1.1585579	[1.11378456264581-1.20513099189349]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	1E-8	8.0		1.1650093	[1.10493126343643-1.22835376686122]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004480	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	3E-6	5.522878745280337		1.1855859	[1.10400745880938-1.27319220749772]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	6E-8	7.221848749616356		1.1783675	[1.11072142428685-1.25013339797474]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	3q28	3	190807727	NR	CCT6P4 - AC092952.1	ENSG00000232610	ENSG00000214147		91328	23238	rs9870207-A	rs9870207	0	9870207	intergenic_variant	1	0.691354	5E-8	7.301029995663981		1.1929355	[1.11921837700174-1.27150779447142]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	1E-9	9.0		1.2150546	[1.14168685260085-1.29313711208919]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	2E-20	19.69897000433602		1.3236618	[1.24799798080348-1.40391301421926]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	1E-16	16.0		1.465133	[1.33389097997879-1.60928789514469]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	10q24.33	10	103934543	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16338	32658	rs7902587-T	rs7902587	0	7902587	intergenic_variant	1	0.0975691	4E-8	7.3979400086720375		1.2930167	[1.18179536270929-1.41470527615789]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	1E-6	6.0		1.1517414	[1.0876255656695-1.21963673962283]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	1E-7	7.0		1.1787505	[1.10925120766678-1.25260426998392]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275360999999999	4E-8	7.3979400086720375		1.1902364	[1.11903760649588-1.2659653630658]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	8q21.13	8	76408119	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538	intron_variant	0	0.9784417	2E-9	8.698970004336019		2.1880746	[1.65336168482279-2.89571888582476]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.486465	6E-6	5.221848749616356		1.1389422	[1.07652961941979-1.20497334696891]	Illumina [11595112] (imputed)	N	ovarian serous carcinoma	http://www.ebi.ac.uk/efo/EFO_1001516	GCST004481	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.048	3E-7	6.522878745280337		1.85	[1.46354854927152-2.33435588308994]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004416	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	9E-11	10.045757490560675		1.5	[1.32777950250739-1.69772989025038]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004416	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	5E-7	6.301029995663981		1.4226197	[1.23974783491848-1.63246639995579]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004414	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	4q32.3	4	164987569	NR	AC106872.4			ENSG00000248229			rs4691139-G	rs4691139	0	4691139	non_coding_transcript_exon_variant	0	0.467	4E-7	6.3979400086720375		1.1581223	[1.09413051760919-1.22585676557555]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004414	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	1E-14	14.0		1.3346913	[1.24035297950519-1.43620468676761]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004414	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	7E-6	5.154901959985743		1.1804551	[1.0983093028467-1.26874471717965]	Illumina [11595112] (imputed)	N	carrier status, ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0007658, http://www.ebi.ac.uk/efo/EFO_0001075	GCST004414	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	3q28	3	190807727	NR	CCT6P4 - AC092952.1	ENSG00000232610	ENSG00000214147		91328	23238	rs9870207-A	rs9870207	0	9870207	intergenic_variant	1	0.691354	3E-6	5.522878745280337		1.0994674	[1.05569458307584-1.14505523813592]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	1E-7	7.0		1.0802581	[1.04978354993499-1.11161732010102]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	8E-8	7.096910013008056		1.0766991	[1.04796689850078-1.10621911687371]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	6p22.1	6	28512858	NR	GPX6, GPX6			ENSG00000281185, ENSG00000198704			rs6456822-T	rs6456822	0	6456822	intron_variant	0	0.690887	1E-6	6.0		1.0714362	[1.04202715140265-1.10167527662683]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	4E-10	9.397940008672037		1.1702297	[1.11383386875217-1.22948084125145]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-26	25.154901959985743		1.232938	[1.18577432499114-1.28197774659809]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	5E-64	63.30102999566398		1.3368285	[1.29251250189538-1.38266389898672]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	2E-11	10.698970004336019		1.11572	[1.08085025008502-1.15171484355914]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	0	144962376	intron_variant	0	0.309302	4E-11	10.397940008672037		1.0959264	[1.06647199521962-1.12619421828606]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q12	17	37733029	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776	intron_variant	0	0.41189	2E-10	9.698970004336019		1.09	[1.06-1.12]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q12	17	37739849	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755	intron_variant	0	0.48646500000000004	8E-9	8.096910013008056		1.077992	[1.05087168925156-1.10581210313382]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	2E-19	18.69897000433602		1.1611373	[1.12396655984348-1.19953742102822]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	2E-17	16.69897000433602		1.1311107	[1.09941695678777-1.16371793958399]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	2E-19	18.69897000433602		1.1357577	[1.10479964302488-1.16758323338693]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	2E-8	7.698970004336019		1.086051	[1.05456961053472-1.11847227897416]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	8q24.21	8	127805637	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651	intron_variant	0	0.461222	2E-9	8.698970004336019		1.0802044	[1.05286500127646-1.10825354962066]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	5E-10	9.301029995663981		1.0834533	[1.05604177574809-1.1115762691869]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319015999999999	4E-14	13.397940008672037		1.1120843	[1.08193543636327-1.14307327686388]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319447	4E-14	13.397940008672037		1.1121821	[1.0819829343715-1.14322428681774]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.0481682	5E-38	37.30102999566398		1.4494933	[1.3698151996842-1.53380589540381]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	4q26	4	119028805	NR	SYNPO2			ENSG00000172403			rs17329882-C	rs17329882	0	17329882	intron_variant	0	0.241	3E-6	5.522878745280337		1.07509	[1.0431816063-1.1079744406]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1279675	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690	intron_variant	0	0.259806	3E-8	7.522878745280337		1.0865872	[1.05501477967445-1.11910451351639]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	5p15.33	5	1285859	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526	intron_variant	0	0.332078	7E-10	9.154901959985743		1.0913801	[1.06151189081851-1.12208885346329]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA				NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2E-8	7.698970004336019		1.1555611	[1.09892839652449-1.21511227508431]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	8q24.21	8	128529685	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482	intron_variant	0	0.867974	7E-16	15.154901959985743		1.1769707	[1.13116083835271-1.22463593511406]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	9p22.2	9	16915876	NR	BNC2 - AL162725.2	ENSG00000173068	ENSG00000237153		45033	1635	rs10962692-G	rs10962692	0	10962692	intergenic_variant	1	0.799624	9E-36	35.045757490560675		1.2424945	[1.20065901834152-1.28578755258347]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA				NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	8E-10	9.096910013008056		1.1083262	[1.07253217567565-1.14531490798434]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	10p12.31	10	21589903	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	0	144962376	intron_variant	0	0.309302	8E-10	9.096910013008056		1.0908245	[1.06101278339562-1.12147377629663]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	15q26.1	15	90963407	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282	2631	rs8037137-C	rs8037137	0	8037137	intergenic_variant	1	0.134	5E-7	6.301029995663981		1.098901	[1.06-1.15]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q11.2	17	30854208	NR	ATAD5, AC130324.2			ENSG00000176208, ENSG00000265334			rs143663961-A	rs143663961	0	143663961	intron_variant	0	0.72942	1E-7	7.0		1.0819896	[1.05072828447598-1.11418107368593]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q21.31	17	45489971	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586	intron_variant	0	0.181254	2E-13	12.698970004336019		1.1339011	[1.09660984313914-1.1724605092959]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	17q21.32	17	48423311	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826	intron_variant	0	0.267801	8E-13	12.096910013008056		1.1105318	[1.07914609971847-1.14283031731538]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	19p13.11	19	17279482	NR	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	0.295975	2E-17	16.69897000433602		1.1302502	[1.09887004937136-1.1625264094177]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.898635	3E-7	6.522878745280337		1.1211612	[1.07314763387262-1.17132308995474]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	2q13	2	111061081	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109	intron_variant	0	0.251869	8E-7	6.096910013008056		1.0780069	[1.04637703624974-1.11059270801828]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls	NA	12q24.31	12	120965921	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249	splice_region_variant	0	0.417632	6E-6	5.221848749616356		1.0621586	[1.0348111352015-1.09022867520121]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004415	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	3q25.31	3	156717851	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923	29495	rs62274041-G	rs62274041	0	62274041	intergenic_variant	1	0.048	2E-57	56.69897000433602		1.57	[1.48-1.66]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q31.1	2	176178498	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs6755777-T	rs6755777	0	6755777	non_coding_transcript_exon_variant	0	0.319	3E-15	14.522878745280337		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	2q31.1	2	176172583	NR	HOXD3, AC009336.2, HAGLR			ENSG00000128652, ENSG00000278500, ENSG00000224189			rs711830-A	rs711830	0	711830	3_prime_UTR_variant	0	0.319	3E-15	14.522878745280337		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	1p34.3	1	37630749	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170	intron_variant	0	0.221	1E-9	9.0		1.1	[1.07-1.13]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	18q11.2	18	23825589	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244	intron_variant	0	0.275	2E-7	6.698970004336019		1.11	[1.07-1.16]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls	NA	22q12.1	22	28538325	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807	intron_variant	0	0.899	9E-6	5.045757490560675		1.1	[1.05-1.15]	Illumina [11595112] (imputed)	N	ovarian carcinoma	http://www.ebi.ac.uk/efo/EFO_0001075	GCST004462	Genome-wide genotyping array
